Afrique

Face à la multiplication des attaques menées par des jihadistes dans le sud du Mali, la junte a mis en place une nouvelle mesure sécuritaire : l’instauration de zones d’intérêt militaires. Précisions de Serge Daniel, correspondant de France 24 en Afrique de l'Ouest.

Au Sénégal, Ousmane Sonko a été réélu samedi à la tête du Pastef lors du premier congrès du parti. Cette réélection intervient dans un contexte de rupture avec le président Bassirou Diomaye Faye, qui l’a limogé de la Primature en mai dernier après plusieurs mois de tensions. Analyse avec Mehdi Ba, journaliste à Jeune Afrique.

Des milliers de personnes originaires d’Afrique de l’Ouest tentent depuis des années la migration clandestine au départ des côtes de leurs pays en empruntant la dangereuse route de l’Atlantique pour gagner l’Europe, à bord d’embarcations surchargées et souvent vétustes.

South African President Cyril Ramaphosa and Health Minister Aaron Motsoaledi at the official launch of the new injectable drug for HIV prevention, Lenacapavir. Credit: GCIS

By Ed Holt
BRATISLAVA, Jun 9 2026 (IPS)

As South Africa officially launches the rollout of a groundbreaking HIV prevention drug,  civic groups in the country have slammed the plan, saying it will not reach anywhere near enough people.

President Cyril Ramaphosa on June 5 launched the roll-out in South Africa of lenacapavir, a twice-yearly injectable HIV pre-exposure prophylaxis (PrEP) drug that has been shown to offer almost complete protection against the disease, billing it as a ‘historic event’.

But activists say there is nothing to celebrate, warning the targets set in the rollout are too low, and the volumes of the drug provided by the pharma firm behind its development, Gilead, are tiny.

“In an ideal world, South Africa would not be rolling out lenacapavir as a small pilot. We would be treating it as an epidemic-ending intervention. The objective should be to get millions of people onto lenacapavir as quickly as possible, not a few hundred thousand over several years,” Tian Johnson, founder and strategist of the Pan-African health justice advocacy group, African Alliance, told IPS.

“South Africa has the world’s largest HIV epidemic. We also helped generate the scientific evidence that made lenacapavir possible. An appropriate response would therefore be a national scale-up plan linked to epidemiological need, not constrained by artificial scarcity created by patent monopolies, donor allocations, and supply decisions made outside the country,” he added.

South Africa has the world’s highest burden of HIV, with around 8 million people living with HIV. In 2024 it recorded 170,000 new infections, accounting for roughly 13% of the 1.3 million new cases globally that year.

Lenacapavir has been shown in trials to provide almost complete protection against HIV acquisition. It has been praised not just for its effectiveness but also for its potential for very high adherence, as it is an injection given only every six months.

Civic groups say that if rolled out in a timely manner and with greater volumes, it could avert up to 52,200 new infections per year in South Africa alone.

They also point to modelling which has shown that around 2 million people in South Africa need to be taking lenacapavir annually for it to have a real impact on the number of new HIV infections.

But the government’s rollout is expected to reach only around 450,000 people over the next two years. Moreover, only just under 38,000 doses have so far arrived in the country.

Activists blame adversarial US policy and effective monopolies on the drug’s supply for this and say it has highlighted concerns over who has real control over efforts to end the epidemic in the country.

The Global Fund to Fight Aids, TB and Malaria (GF) and the United States President’s Emergency Plan for Aids Relief (PEPFAR) have historically been central to funding South Africa’s HIV response.

But days after Donald Trump entered the White House early last year, PEPFAR slashed around half of its funding for HIV in South Africa – what is left of it is due to run out this month.

So far, the Trump administration is refusing to fund lenacapavir for South Africa as the two countries lock horns politically and ideologically.

This means that the doses to be used in South Africa over the next 18 months to two years will be funded by the Global Fund and are expected to be only sufficient for 456,000 people.

Meanwhile, since Gilead is currently the only manufacturer of lenacapavir and generics are not available on the market yet, there is no alternative path available to secure more doses for the rollout.

Currently the cost of Lenacapavir is about USD 28,000 per person a year in the U.S., but Gilead has issued six licences to companies to manufacture generics, which will be available to 120 low- and middle-income countries. These are expected to become available in 2027, potentially for as little as USD 40 per person per year.

Earlier this year, it was announced the South African government was working to identify a local company to manufacture lenacapavir. Once identified, that company would then be recommended to Gilead for a voluntary licence to produce the drug.

In 2024, Gilead granted such licences to six generic manufacturers across India, Egypt and Pakistan to produce and supply the drug ⁠to 120 low- and middle-income countries. At the time, critics pointed out that no South African ​drugmakers were included.

Gilead has said it is open to adding another licence for local manufacturing in Sub-Saharan Africa. But activists warn that any final decision on a licence will rest with the company.

The groups also highlighted previous delays in the rollout of the programme, which had initially been scheduled to begin in April. When the first doses arrived in South Africa in March and April, they were subject to obligatory regulatory tests. Gilead could have asked for an exemption to the tests but did not, activists claim.

They say all this means properly protecting people against HIV in South Africa is effectively dependent on a pharmaceutical firm and US political policy.

“Gilead currently exercises extraordinary influence over who receives lenacapavir, in what quantities, and on what timeline. When a country with the world’s largest HIV epidemic cannot independently determine access to a medicine that was partly researched within its own borders, something is fundamentally wrong with the balance of power. The uncomfortable reality is that key decisions affecting South Africa’s HIV response are still being made in corporate boardrooms and donor negotiations rather than in South Africa. That should concern everyone, regardless of where they stand on this rollout,” said Johnson.

“Many countries are receiving doses funded by the US, and then also being funded as a result of re-allocation of already committed Global Fund funding repurposed for lenacapavir. The US is refusing to fund South Africa ‘s lenacapavir program, even though there is no better example of a country that needs lenacapavir, and [the programme] would immediately show impact,” Asia Russell, Executive Director of HIV advocacy group Health Gap, told IPS.

“The US government has stated its goal is to bend the curve of new HIV infections, but it is blocking access to the doses urgently needed in South Africa, which means it will fail to reach its goal. It should immediately reverse this decision, stop bullying  South Africa, and provide doses – South Africa’s minuscule allocation of lenacapavir only from the Global Fund means the pandemic will continue raging in South Africa,” she added.

It will also have a detrimental effect on wider efforts to tackle HIV outside South Africa, others say.

“South Africa accounts for more than 13 percent of new HIV infections globally each year, and is a home for millions of other public health care recipients from other countries who benefit from the South African health care system. The US government’s refusal to support South Africa with lenacapavir and cut off other funding is not only cruel but also contributes to delays in ending the HIV pandemic,” Bellinda Thibela, Coordinator for Health Justice and Human Rights at Health GAP, told IPS

Meanwhile, activists point out what they see as another huge injustice in the situation.

South Africa was key to the development of the drug – it hosted testing sites, its clinics were used in research, and subjects came from its communities – yet it is now struggling to secure sufficient supplies of that same drug.

“South Africa played a pivotal role in the clinical development of lenacapavir, hosting 25 of the 28 trial sites that participated in the PURPOSE 1 Phase III study of this groundbreaking long-acting HIV prevention tool. Yet, despite this substantial contribution, my country has found itself in the difficult position that, following approval by the US FDA and rollout in several high-income countries, access to lenacapavir at scale for PrEP remains abysmally low and challenging. And not just for South Africa,” Fatima Hassan of the Health Justice Initiative (HJI), told IPS.

“This underscores persistent inequities within the global innovation ecosystem, where countries that bear a disproportionate burden of disease and contribute significantly to research and development often face delays in accessing the very health technologies they helped bring to fruition. It also raises important questions about local manufacturing, technology transfer, regulatory capacity, affordability, and equitable access in markets that are frequently perceived as less commercially attractive, despite their central role in generating the evidence that drives global health innovation and the development of new health technologies,” she added.

In a statement, Gilead said the launch of the rollout was an important step toward expanding access to lenacapavir for communities most affected by HIV.

“South Africa is at the heart of global efforts to end HIV. With the country’s launch of lenacapavir, there is now an opportunity to rapidly accelerate progress,” said Daniel O’Day, Chairman and Chief Executive Officer of Gilead Sciences. “Through partnerships with country leadership, the Global Fund, and the U.S. State Department via PEPFAR, Gilead is working to bring lenacapavir to the communities most in need, ahead of the broad rollout of generic versions of the medicine.”

The company also highlighted what it said was its commitment to supporting broad, equitable and sustainable access to lenacapavir for HIV prevention globally,  pointing to its royalty-free voluntary licence agreements with six manufacturers enabling generic supply across 120 low- and lower-middle-income countries to support long-term, lower-cost medication supply.

“As highlighted by today’s announcement and the strong, coordinated leadership demonstrated in South Africa, the continued collaboration between countries, global health partners and industry will be critical to reaching people with new innovations at scale, reducing new HIV infections and advancing our shared goal of ending HIV as a public health threat,” the company said in the statement.

Civic groups have called on South Africa’s government to scale up the volumes for the rollout and expand it to make sure it can be accessed by more people – they have criticised the fact that out of more than 3,000 public clinics, just 300 in 23 districts have been chosen for the rollout, and mobile clinics, which would be more likely accessed by some communities, are not being used.

They also want to see more pressure put on Gilead to drastically expand its current licence territories to help manufacture lenacapavir.

“At the moment, we have a Gilead-driven launch event, but we do not have a credible epidemic-ending plan. The bigger issue is that South Africa appears to have accepted the limits imposed by Gilead rather than challenging them,” said Johnson.

He added that under the current roll-out plan a crucial opportunity to end the HIV epidemic sooner in South Africa was being missed.

“The tragedy is that South Africa is not dealing with a scientific failure –  the science worked. Lenacapavir is one of the most promising HIV prevention tools ever developed. What we are facing is a political and access failure. If we know that roughly two million people need access annually to achieve maximum public health impact, then a faux roll out reaching a fraction of that number inevitably means preventable infections will continue occurring.

“Every year we delay large-scale access is another year in which tens of thousands of South Africans will acquire HIV despite the existence of a prevention tool capable of dramatically reducing transmission. This is why the debate is not really about a rollout. It is about whether South Africa intends to end the epidemic or manage it. The current approach manages the epidemic dismally. An epidemic-ending strategy would look very different,” Johnson said.

IPS UN Bureau Report

 

Follow @IPSNewsUNBureau
!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+'://platform.twitter.com/widgets.js';fjs.parentNode.insertBefore(js,fjs);}}(document, 'script', 'twitter-wjs');

 

Inter Press Service (IPS), IPS News,

Related Articles

• Vulnerable Populations Will Suffer With UNAIDS Early Closure
• XDR-TB Drug Trial Participants Continue to Celebrate its Success
• Activists Challenge Pharma Company Gilead Over HIV Medication

La FIFA a déclaré dans un communiqué qu'elle n'avait aucun rôle à jouer dans les décisions de voyage des pays hôtes du tournoi.

Serigne Khadim Mbacké, issu d’une des plus prestigieuses lignées maraboutiques du pays, a été condamné à vingt ans de réclusion pour viol et acte pédocriminel infligé à 28 élèves d’un quartier miséreux de la ville sainte de Touba.

– Son Excellence Naaba Koanga, Chef du Canton de Sao, province du Kourwéogo ;
– Le Tingsoaba Saaga, Chef de terre de Kinana,
– Son Excellence Naaba Sigri de Saponé,
– Les grandes familles SAWADOGO, NABOLE, SINARE et TAONSA à Kinana, Koui Ouagadougou et France,

Les familles aillées :
– ILBOUDO et DOUAMBA à Saponé et à Ouagadougou,
– SAWADOGO à Goupana et Ouagadougou,
– NITIEMA à Bingo et Ouagadougou,
– SODRE à Bobo Dioulasso,
– SAWADOGO à Ouahigouya et Ouagadougou
– SOUGUE à Boromo, Ouagadougou et France.

– SAWADOGO Lankoudougou Alfred, Conseiller d'administration scolaire et universitaire à la retraite à Tampouy/Ouagadougou.
Les enfants : Francine Prudence, Nina Jacqueline, Natacha Ghislaine, Nérée Aubin et Marina Prisca ;
Les petits enfants :

Ont la profonde douleur de vous annoncer le décès de leur épouse, fille, sœur, tante, mère et grand-mère de Mme SAWADOGO/ILBOUDO Kouliga Madeleine le dimanche 7 juin 2026 à Ouagadougou dans sa 68ème année de suite de courte maladie.
Les familles vous informent que le programme des obsèques se déroulera comme suit :

*Mercredi 10 juin 2026 :
- 20h30 : Veillée de prières au domicile familial à Tampouy sis à côté des écoles primaires publiques Tampouy C et D.
*Jeudi 11 juin 2026 :
– 6h00 : Levée du corps à la morgue du Centre Hospitalier Universitaire Yalgado Ouédraogo suivie d'un bref passage au domicile familial à Tampouy sis à côté des écoles primaires publiques Tampouy C et D.
– 08h30 : Messe d'absoute à l'Église paroissiale Saint Jean-Marie Vianney de

Tampouy.
À l'issue de la célébration, départ du cortège funèbre pour l'inhumation au village de Kinana, situé au nord de Pabré sur l'axe Tema-Bokin, à environ 50 km de Ouagadougou.

« Je suis la résurrection et la vie. Celui qui croit en moi vivra, même s'il meurt ; et quiconque vit et croit en moi ne mourra jamais. » Jean 11, verset 25
Union de prières pour le repos de son Âme. Que le Seigneur l'accueille dans sa paix et sa lumière éternelle.

Contacts pour toute fin utile : 65 86 45 45 / 54 98 47 87 / 70 68 46 36

Au Sénégal, Ousmane Sonko, fraîchement réélu à la tête du Pastef, a tenu ce dimanche 7 juin un meeting d’investiture à Diamniadio, en périphérie de Dakar. Dans un contexte de brouille avec le chef de l'État Bassirou Diomaye Faye, Ousmane Sonko a néanmoins affirmé qu’il n’existait « aucune crise institutionnelle » au Sénégal.

Le procureur de la Cour pénale internationale (CPI), Karim Khan, a été suspendu de ses fonctions, lundi 8 juin. La procédure disciplinaire ouverte contre lui a été renvoyée aux 125 États membres de la Cour. Ils devront décider ou non de le destituer.

Sa Majesté le Naaba Kiiba, roi du Yatenga
La grande famille PANANDTIGRI/OUEDRAOGO
Les grandes familles YERBANGA, SIDIBE, TRAORÉ, NACANABO, KANAZOE, BOUDA, YE

Les familles alliées :
•NEBIE à Naponé
•OUEDRAOGO à Kalsaka
•OUEDRAOGO à Bilbalgho
•OUANDAOGO/TRAORE à Ouaga et Tenkodogo
•BARRY à Ouahigouya/Bema
•OUEDRAOGO à Zouma/Pabre
•DOH à Dohoun
•OUEDRAOGO à Ouahigouya
•TALL à Ouahigouya
•OUEREMI à Aorèma
•BREUNING en Allemagne
•PASCAL en Espagne
•ANDERSON aux États-Unis
•BANGBATINBO à Ouahigouya

Les épouses :
•Madame OUEDRAOGO née NEBIE Brigitte à Kamsonghin
•Madame OUEDRAOGO née OUEDRAOGO Tibo Fati à la Patte d'oie

Les enfants :
•OUEDRAOGO Adama Tréboul (Vieux)
•OUEDRAOGO Aminata Tréboul (Bibi)
•OUEDRAOGO Tréboul Harouna
•OUEDRAOGO Tréboul Hamidou (Doudou)
•OUEDRAOGO Tréboul Abdoulaye (Ben)
•OUEDRAOGO Tréboul Moussa - USA
•OUEDRAOGO Tréboul Boureima (Petit Papa)
•OUEDRAOGO Tréboul Mohamed - Allemagne
•OUEDRAOGO Tréboul Alidou - Allemagne
•OUEDRAOGO Tréboul Habibou (Dépo) - USA

Les petits fils et l'arrière petite fille

Ont la profonde douleur de vous annoncer le rappel à DIEU de leur frère, époux, père, beaux père, grand-père et arrière grand-père,
Monsieur OUEDRAOGO Tréboul Saïbou, commandeur de l'ordre national, opérateur économique, PDG des hôtels de l'Amitié de Ouahigouya et Gorom Gorom, hôtel Oasis de Dori et PDG de l'entreprise Castors de Ouahigouya ;
Décès survenu le Dimanche 07 juin 2026 à Ouagadougou à l'âge de 89 ans.

Programme des Obsèques
Jeudi 11 juin 2026
•06h : levée du corps à la morgue de la clinique EL FATEH SUKA et transfert à Ouahigouya
•14h : enterrement prévu à Lillgomde dans son village natal (Ouahigouya) suivi du doua.

Union de prière

Le marché des drogues évolue « à un rythme effréné, et la diversité des substances dans les rues européennes devient de plus en plus imprévisible », indique Lorraine Nolan, la directrice exécutive de l'Agence de l'Union européenne sur les drogues (EUDA). Ce qui rend les consommateurs plus à risques. 

Depuis plus d’une semaine, la « révolution des flamants roses » prend de l’ampleur en Albanie. En cause : un méga-projet de complexe touristique de luxe à environ quatre milliards de dollars, porté par Jared Kushner et Ivanka Trump, sur l’île de Sazan et la lagune de Narta, deux sanctuaires écologiques majeurs de l’Adriatique. Entre intimidation, passe-droits législatifs et soupçons de corruption, ce dossier cristallise la colère des citoyens face aux dérives autoritaires du Premier ministre Edi Rama. Entretien avec Miguel Roán, docteur en science politique et spécialiste des Balkans.

Aslam aleykoum chers tous et toutes
Inna lillahi wa inna ilaihi raji'un."

Les grandes familles TAGO et GUIBLA à Pella, Ouarkoye, Bibiou, Pangogo, Bobo- Dioulasso, Dédougou, Ouagadougou (Burkina Faso), Angola, Maroc, USA, Mosambique, Corée, Belgique et Alliés,
les grandes familles, KOURAOGO, KOUMBEMA KIENTEGA, OUEDRAOGO, KOALGA
les familles alliées OUEDRAOGO, KOMBELEMSIGRI, COMPAORÉ, KINDA, KONÉ, ZONGO, ZOUNGRANA, SENTISSI, SORÉ, YELBI, YOUNGA. SANKARA, NAKOULMA, KABORÉ et TOUGMA,
La veuve TAGO née ZOUNGRANA Liliane Florence Djamila, et les enfants Asmaou Fabiola et Adama Kamel,
les frères, soeurs, cousins, cousines, neveux, nièces et les petits enfants,

Adressent leurs sincères remerciements à tous ceux et à toutes celles qui de près ou de loin leur ont témoigné de leur compassion, affection, solidarité et soutien multiforme lors du rappel à Dieu le 27 mai 2026 suivi des obsèques le 29 mai 2026 et du Doua le 4 juin 2026 de leur époux, père, fils, oncle, beau père, grand-père, Monsieur TAGO Mamadou* .

Elles s'excusent de ne pouvoir citer des noms de peur d'en oublier et surtout prient le Tout-Puissant d'accorder sa miséricorde au défunt et de l'accueillir dans son humble paradis. Qu'il veille sur chacun(e) de vous et sur vos familles respectives, et vous comble de ses bienfaits.

Les supporters du monde entier affirment que les interdictions de voyager et les réglementations en matière de visas aux États-Unis leur donnent le sentiment d'être exclus de la Coupe du monde.

Les supporters du monde entier affirment que les interdictions de voyager et les réglementations en matière de visas aux États-Unis leur donnent le sentiment d'être exclus de la Coupe du monde.

La circulation est totalement interrompue sur la Route nationale 44 (RN44) à la suite de l’effondrement, dimanche 7 juin 2026, du pont Ituri 2. Cet ouvrage stratégique, qui relie les provinces du Nord-Kivu et de l’Ituri, a cédé sous le poids d'un camion transportant des marchandises. Cet incident majeur perturbe gravement les opérations militaires contre les rebelles des ADF ainsi que l’approvisionnement économique de plusieurs provinces.

Les habitants de Bunia modifient leurs comportements quotidiens pour se protéger contre l’épidémie de la maladie à virus Ebola.

La coalition de l’opposition C64 a annoncé, lundi 8 juin, avoir décidé de différer le dépôt de sa plainte contre le président de la République, initialement prévu ce mardi 9 juin. La plateforme politique évoque la nécessité d’intégrer de nouveaux éléments juridiques et factuels dans son dossier.